Using a patented magnetic closure, Babynetic's bibs are designed to snap and stay secured while holding up to four pounds of food. Photo courtesy of Babynetic

Ashley Gooch has taken her entrepreneurial spirit from the fitness studio to the finger foods.

The Houston-based founder of high-end cycling studio RYDE and mom of three has launched a new baby gear brand, Babynetic. The company debuted its first product this month: the Babynetic bib.

Using a patented magnetic closure, the colorful platinum-grade silicone bibs are designed to snap and stay secured while holding up to four pounds of food. The snap is intended to be easy for parents to use, but more difficult for messy little hands to remove without assistance.

Thanks to their magnetic snap, the bibs can also be stored or hung on the fridge or dishwasher for easy access for busy parents and caregivers. The smooth silicone (free of BPA, BPS, phthalate and PVC) is intended to be easy to wipe down and clean and comes in a variety of bold fruit-inspired colors.

The product was born out of necessity for Gooch and her Austin-based business partner and fellow mom Jennifer Zimmer. The duo met while attending Texas A&M University. Zimmer currently works full-time as a customer success manager for the Central South region at California-based software development firm Workday, according to her LinkedIn.

“As busy moms ourselves juggling careers and with five kids between us, we needed baby gear we could rely on,” Gooch said in a statement.

“All of our kids could pull of their bibs at mealtime,” Zimmer added.

Gooch and Zimmer worked with product Los Angeles-based full-stack produce development company Mvnifest to prototype and build the line. Mvnifest was launched by Samantha Rose, founder and CEO of Sorry Robots, who got her start designing a silicone kitchen spatula, eventually growing into a full line of kitchen tools known as the brand GIR.

Babynetic is currently taking orders for the Babynetic bibs on its website, and shipping began last week on April 24. By Spring 2025, the team aims to release baby onesies that feature their patented magnetic closure.

“We wanted people to use Babynetic products and think, ‘This is so much better,’” Gooch said.

Ashley Gooch (right) co-founded the company with Austin-based business partner and fellow mom Jennifer Zimmer. Photo courtesy of Babynetic

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.